menu search

Exact sciences shares gain on results from non-invasive cancer screening test

Shares of Exact Sciences Corp. EXAS, +0.98% gained more than 7% in premarket trading Wednesday after the company released results from a study of its ...

June 21, 2023, 8:18 am

Exact sciences says its new colon cancer test shows 30% lower false positive rate

Exact Sciences said on Tuesday its next-generation screening test for colon cancer showed 30% lower fal...

June 20, 2023, 4:24 pm

Mersana (mrsn) down on partial ovarian cancer study hold

Mersana's (MRSN) shares decline on partial clinical hold by the FDA on UP-NEXT and UPGRADE-A studies evaluating upifitamab rilsodotin to treat platinu...

June 16, 2023, 12:20 pm

Mustang (mbio) up 9% on rare blood cancer study's upbeat data

Updated data from a clinical study shows that treatment with Mustang Bio's (MBIO) CAR T cell therapy has achieved an overall response rate of 83% in p...

June 13, 2023, 3:04 pm

Novocure's lung cancer device extends survival in late-stage study

Novocure said on Tuesday its experimental device to treat a type of lung cancer showed a statistically ...

June 6, 2023, 8:38 am

Astrazeneca plc (azn) asco investor event

AstraZeneca PLC (NASDAQ:AZN ) ASCO Investor Event June 5, 2023 7:00 PM ET CorporateParticipants Andy Barnett - VP Global Head of IR Roy Herbst - Deput...

June 6, 2023, 7:17 am

Bristol myers (bmy) announces upbeat data from nsclc study

Bristol Myers (BMY) reports encouraging four-year clinical efficacy results from its lung cancer study ...

June 5, 2023, 11:25 am

Moderna cancer vaccine used with merck keytruda reduces risk of deadly skin cancer spreading

Melanoma is responsible for the large majority of skin cancer deaths, according to the American cancer s...

June 5, 2023, 9:17 am

Lava (lvtx) up on j&j's (jnj) cancer study candidate selection

LAVA's (LVTX) shares soar as partner J&J (JNJ) selects a lead candidate for development in clinical studies for cancer....

June 2, 2023, 12:09 pm

Eli lilly releases new data on breast cancer, lymphoma treatments

Eli Lilly & Co. LLY, +1.64% on Friday released new clinical trial data on treatments for certain types of early breast cancer and mantle cell lymphoma...

June 2, 2023, 8:03 am

Astrazeneca (azn) drug combo meets endometrial cancer study goal

AstraZeneca (AZN) reports statistically significant results from a late-stage study evaluating the combination of Imfinzi and Lynparza in patients wit...

May 29, 2023, 8:50 am

Pds biotech (pdsb) up 32% on interim data from hpv cancer study

PDS Biotech's (PDSB) shares gain as it announces encouraging interim data from the VERSATILE-002 study for treating HPV16-positive cancer patients....

May 26, 2023, 9:35 am

Immutep (immp) up on initial data from lung cancer study

Immutep (IMMP) shares surge on encouraging initial data from a triple combination therapy study, INSIGHT-003, for non-small cell lung cancer....

May 25, 2023, 4:17 pm

Mirati's (mrtx) sitravatinib fails lung cancer study, stock down 8%

Mirati Therapeutics' (MRTX) phase III study evaluating sitravatinib as a combination therapy in certain NSCLC patients fails to meet its primary endpo...

May 25, 2023, 3:47 pm

Pds biotech (pdsb) completes enrollment for hpv cancer study

PDS Biotech (PDSB) shares gain as it completes patient enrollment in the second arm of the VERSATILE-002 study for treating HPV16-positive cancer pati...

May 19, 2023, 1:01 pm

Immutep (immp) surges 65% on upbeat lung cancer study data

A mid-stage study data shows that Immutep's (IMMP) lead candidate as a combination therapy in first-line NSCLC achieved better-than-expected overall s...

May 18, 2023, 1:48 pm

Atossa therapeutics ceo steven quay weighs in on us agency's revised mammogram guidelines

Atossa Therapeutics Inc (NASDAQ:ATOS) CEO Steven Quay has offered a set of recommendations to the United States Preventive Services Task Force (USPSTF...

May 11, 2023, 11:51 am

Exact sciences to participate in may investor conference

MADISON, Wis. , May 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer ...

May 1, 2023, 6:00 am

Illumina ceo touts grail's 100% revenue growth amid proxy fight with icahn

CEO Francis deSouza said San Diego-based Illumina can significantly expand the market for Grail's early cancer...

April 26, 2023, 2:26 pm

Legend (legn) stock up 20% on data leak from blood cancer study

Leaked data from Legend Biotech's (LEGN) phase III study of the blood cancer drug, Carvykti, shows a 74% reduction in risk of death or tumor progressi...

April 20, 2023, 12:11 pm


Search within

Pages Search Results: